GlassScriptPhysician profile
John William Perry
NPI 1306379813
$6,180.00
in general payments reported to CMS, 2019-2025
26 companies · $996 in 2025
The $996 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $471 · 2022: $2,154 · 2023: $806 · 2024: $1,753 · 2025: $996.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,610 · Travel and Lodging: $945.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,609.67 |
| Travel and Lodging | $945.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $1,800.88 | 2022-2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| W. L. Gore & Associates, INC. | $1,417.73 | 2022-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Excluder Aaa Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Penumbra, INC. | $832.80 | 2023-2025 | Indigo System, Penumbra System |
| Medtronic Vascular, INC. | $459.32 | 2019 | |
| Endologix LLC | $343.36 | 2022-2025 | Afx2 Bifurcated Endograft System |
| Abbott Laboratories | $267.52 | 2024-2025 | Diamondback Peripheral, Esprit, Supera |
| Stryker Corporation | $222.44 | 2025 | Flowtriever, Artix Mt |
| Philips North America LLC | $136.46 | 2022-2023 | |
| Shockwave Medical, INC | $118.25 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $101.21 | 2023-2025 | Concertotm, Endurant Iis, Hawkone |
| Inari Medical, INC. | $95.62 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $71.40 | 2022 | |
| Lemaitre Vascular, INC. | $58.34 | 2023-2025 | Artegraft Vascular Graft, Restoreflow |
| Smith+Nephew, INC. | $28.16 | 2025 | Renasys Touch, Pico 14 |
| Tactile Systems Technology INC | $26.24 | 2025 | Nimbl, Flexitouch Plus |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neuros Medical, INC. | $24.66 | 2025 | Altius |
| Terumo Medical Corporation | $22.18 | 2022 | |
| Cordis US Corp. | $21.26 | 2023 | Mynx Control |
| Bolton Medical INC | $20.05 | 2025 | Treo Abdominal Stent-Graft System |
| Bard Peripheral Vascular, INC. | $17.97 | 2025 | |
| Recordati_rare_diseases_inc. | $17.91 | 2023 | Isturisa |
| Cardiva Medical, INC. | $17.83 | 2023 | Cardiva Vascade 6/7f Vcs |
| Pfizer INC. | $16.49 | 2024 | |
| Becton, Dickinson and Company | $15.74 | 2024 | Rotarexs 6 F X 135 Cm |
| Cashflow Solutions, LLC | $14.30 | 2025 | Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White |
| Ekos Corporation | $11.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Perry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.